CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.
stocks

Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,860.5014.900.17%
CAC 408,077.803.63-0.04%
DAX 4025,408.64142.110.56%
Dow JONES (US)51,828.62478.640.93%
FTSE 10010,695.2515.260.14%
HKSE24,666.09156.000.64%
NASDAQ27,068.72129.340.48%
Nikkei 22566,327.5636.64-0.06%
NZX 50 Index13,830.6819.570.14%
S&P 5007,743.4139.280.51%
S&P/ASX 2008,690.6025.600.30%
SSE Composite Index3,820.8267.55-1.74%

Market Movers